Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.62−0.29 (-0.09%)
Close on Nov 16, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra total assets
Total assets on the balance sheet at the end of each period.
Penumbra's total assets was $2.03B at Sep 30, 2026. For fiscal 2025 it was $1.83B, up 19.1% from the year before. Over ten years it grew 21.3% a year on average. The highest annual figure on record is $1.83B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.83B | +19.1% |
| FY2024 | Dec 31, 2024 | $1.53B | -1.5% |
| FY2023 | Dec 31, 2023 | $1.56B | +13.5% |
| FY2022 | Dec 31, 2022 | $1.37B | +10.2% |
| FY2021 | Dec 31, 2021 | $1.24B | +51.2% |
| FY2020 | Dec 31, 2020 | $822.98M | +23.6% |
| FY2019 | Dec 31, 2019 | $665.90M | +29.3% |
| FY2018 | Dec 31, 2018 | $515.01M | +8.0% |
| FY2017 | Dec 31, 2017 | $476.67M | +54.6% |
| FY2016 | Dec 31, 2016 | $308.25M | +16.8% |
| FY2015 | Dec 31, 2015 | $263.85M | +117.4% |
| FY2014 | Dec 31, 2014 | $121.38M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.03B | +16.1% |
| Q2 FY2026 | Jun 30, 2026 | $1.97B | +17.9% |
| Q1 FY2026 | Mar 31, 2026 | $1.90B | +19.2% |
| Q4 FY2025 | Dec 31, 2025 | $1.83B | +19.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.74B | +17.9% |
| Q2 FY2025 | Jun 30, 2025 | $1.67B | +9.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.59B | +0.9% |
| Q4 FY2024 | Dec 31, 2024 | $1.53B | -1.5% |
| Q3 FY2024 | Sep 30, 2024 | $1.48B | +0.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.53B | +7.1% |
| Q1 FY2024 | Mar 31, 2024 | $1.58B | +13.2% |
| Q4 FY2023 | Dec 31, 2023 | $1.56B | +13.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.47B | +11.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.43B | +7.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.40B | +7.2% |
| Q4 FY2022 | Dec 31, 2022 | $1.37B | +10.2% |
| Q3 FY2022 | Sep 30, 2022 | $1.32B | +35.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.33B | +57.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.30B | +58.2% |
| Q4 FY2021 | Dec 31, 2021 | $1.24B | +53.6% |
| Q3 FY2021 | Sep 30, 2021 | $973.24M | +24.7% |
| Q1 FY2021 | Mar 31, 2021 | $840.82M | +26.6% |
| Q4 FY2020 | Dec 31, 2020 | $822.98M | +23.6% |
| Q3 FY2020 | Sep 30, 2020 | $810.30M | +31.9% |
| Q2 FY2020 | Jun 30, 2020 | $780.20M | +33.3% |
| Q1 FY2020 | Mar 31, 2020 | $664.24M | +16.8% |
| Q4 FY2019 | Dec 31, 2019 | $665.90M | +29.3% |
| Q3 FY2019 | Sep 30, 2019 | $614.17M | +22.6% |
| Q2 FY2019 | Jun 30, 2019 | $585.11M | +17.2% |
| Q1 FY2019 | Mar 31, 2019 | $568.79M | +16.1% |
| Q4 FY2018 | Dec 31, 2018 | $515.01M | +8.0% |
| Q3 FY2018 | Sep 30, 2018 | $501.01M | +9.1% |
| Q2 FY2018 | Jun 30, 2018 | $499.31M | +19.7% |
| Q1 FY2018 | Mar 31, 2018 | $489.71M | +17.1% |
| Q4 FY2017 | Dec 31, 2017 | $476.67M | +54.6% |
| Q3 FY2017 | Sep 30, 2017 | $459.09M | – |
| Q2 FY2017 | Jun 30, 2017 | $417.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $418.37M | – |
| Q4 FY2016 | Dec 31, 2016 | $308.25M | – |
See a number that looks wrong?